EP3687576
USE OF CANNABIDIOL IN COMBINATION WITH NORFENFLURAMINE OR FENFLURAMINE IN THE TREATMENT OF EPILEPSY
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
1.10.2018:
3.9.2025:
18782178.0
:
30.9.2038:
2.1.2026
:
USE OF CANNABIDIOL IN COMBINATION WITH NORFENFLURAMINE OR FENFLURAMINE IN THE TREATMENT OF EPILEPSY
1.10.2018
3.9.2025
2.1.2026
:
Jazz Pharmaceuticals Research UK Limited:
Building 730 Kent Science Park, Sittingbourne Kent ME9 8AG, GB
:
WHALLEY, Benjamin:
Sittingbourne, Kent ME9 8AG, GB
:
GUY, Geoffrey:
Sittingbourne Kent ME9 8AG, GB
:
KNAPPERTZ, Volker:
Sittingbourne Kent ME9 8AG, GB
:
GRAY, Royston:
Sittingbourne Kent ME9 8AG, GB
:
RANA, Rohini:
Sittingbourne Kent ME9 8AG, GB
:
201715919:
29.9.2017:
GB
:
201806481:
20.4.2018:
GB
:
GB2018052805:
1.10.2018
:
A61K 31/352, A61K 31/165, A61K 31/137, A61K 45/06, A61P 25/08